Comparison of Chronic Pain and High-Impact Chronic Pain
The 2016 National Health Interview Survey found that high-impact chronic pain and chronic pain that does not limit major life activities were linked to various physical and mental conditions.
CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
An Overview of Naloxone for Pharmacists
The most common medications involved in prescription-opioid overdose deaths include methadone, oxycodone, and hydrocodone.
Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Pain Management • March 2021 • 2.00 Credits
Cannabis Use in Pain Patients
-
Cardiology • February 2021 • 2.00 Credits
Assessing Aspirin for Primary CVD Prevention
-
Gastrointestinal Diseases • January 2021 • 2.00 Credits
A Pharmacist's Review of Nausea and Vomiting
Quick Poll
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.